Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MYOBLOC in Adult Upper Limb Spasticity
2020-005553-24Phase 2Terminated
- Sponsor
- MDD US Operations
- Start
- May 2021
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in upper extremity spasticity and Muscle spasm comparing MYOBLOC with Placebo (2 arms). Started May 2021; status: terminated.
02
Drugs
botulinum toxin type b
03
Conditions
upper extremity spasticityMuscle spasm
Beyond the preview
Go deeper on 2020-005553-24.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2020-005553-24.